Abstract
Mutations in the β-glucocerebrosidase gene cause Gaucher disease with the type 1 variant generally presenting later in life with mild disease and type 2 in infancy with severe neuronopathic symptoms. We describe a neonate homozygous for the D409 H mutation with thrombocytopenia, splenomegaly and cholestasis at birth as the major features.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Mehta P, Vasa R, Neumann L, Karpatkin M . Thrombocytopenia in the high risk infant. J Pediatr 1980;97:791–794.
Castle V, Andrew M, Kelton J, Giron D, Johnston M, Carter C . Frequency and mechanism of neonatal thrombocytopenia. J Pediatr 1986;108:749–755.
Uhrynowska M, Maslanka K, Zupanska B . Neonatal thrombocytopenia: incidence, serological and clinical observations. Am J Perinatol 1997;14:415–418.
Sola MC, Christensen RD . Developmental aspects of platelets and disorders in the neonatal period In: Christensen RD, editor. Hematologic Problems of the Neonate. Philadelphia, PA: WB Saunders; 2000. p. 273–309.
Wilcox WR . Lysosomal storage disorders: the need for better pediatric recognition and comprehensive care. J Pediatr 2004;144:S3–S14.
Kolodny EH, Charria-Ortiz G . Storage diseases of the reticuloendothelial system In: Nathan DG, Orkin SH, Ginsburg D, Look AT, editors. Hematology of Infancy and Childhood. 6th ed. Philadelphia, PA: WB Saunders; 2003. p. 1399–1454.
Grabowski GA . Gaucher disease: lessons from a decade of therapy. J Pediatr 2004;144:S15–S19.
Filocam M, Mazzotti R, Stroppiano M, et al. Analysis of the glucocerebrosidase gene and mutation profile in 144 Italian Gaucher patients. Hum Mutat 2002;20:234–235.
Michelakakis H, Skardoutsou A, Mathioudakis J, Dimitriou E, Voudris C, Karpathios T . Early onset severe neurological involvement and D409H homozygosity in Gaucher disease: outcome of enzyme replacement therapy. Blood Cells Mol Dis 2002;28:1–4.
George R, Mcmahon J, Lytle B, Clark B, Lichtin A . Severe valvular and aortic arch calcification in a patient with Gaucher's disease homozygous for the D409H mutation. Clin Genet 2001;59:360–363.
Inui K, Yanagihara K, Otani K, et al. A new variant neuropathic type of Gaucher's disease characterized by hydrocephalus, corneal opacities, deformed toes and fibrous thickening of spleen and liver capsules. J Pediatr 2001;138:137–139.
Author information
Authors and Affiliations
Additional information
Current address of S.S.K.: Division of Genetics, Department of Pediatrics, UMDNJ/Robert Wood Johnson Medical School, New Brunswick, NJ, USA.
Rights and permissions
About this article
Cite this article
Roth, P., Sklower Brooks, S., Potaznik, D. et al. Neonatal Gaucher Disease Presenting as Persistent Thrombocytopenia. J Perinatol 25, 356–358 (2005). https://doi.org/10.1038/sj.jp.7211262
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.jp.7211262
This article is cited by
-
Gaucher disease: clinical phenotypes and refining GBA mutational spectrum in Thai patients
Orphanet Journal of Rare Diseases (2021)
-
Glucosylceramide transfer from lysosomes—the missing link in molecular pathology of glucosylceramidase deficiency: A hypothesis based on existing data
Journal of Inherited Metabolic Disease (2006)